{
    "organizations": [],
    "uuid": "e25d36333e0d004a55a834514a341fb13a2e5b12",
    "author": "",
    "url": "https://www.reuters.com/article/brief-fda-clears-pluristems-expanded-acc/brief-fda-clears-pluristems-expanded-access-program-to-initiate-treatments-of-critical-limb-ischemia-idUSASB0C0BN",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Clears Pluristem’s Expanded Access Program To Initiate Treatments Of Critical Limb Ischemia",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 9, 2018 / 12:22 PM / in 10 minutes BRIEF-FDA Clears Pluristem’s Expanded Access Program To Initiate Treatments Of Critical Limb Ischemia Reuters Staff 1 Min Read \nJan 9 (Reuters) - Pluristem Therapeutics Inc: \n* PLURISTEM THERAPEUTICS - U.S. ‍FDA CLEARED CO‘S EXPANDED ACCESS PROGRAM FOR USE OF PLX-PAD CELL TREATMENT IN PATIENTS WITH CRITICAL LIMB ISCHEMIA​ \n* FDA CLEARS PLURISTEM’S EXPANDED ACCESS PROGRAM TO INITIATE TREATMENTS OF CRITICAL LIMB ISCHEMIA OUTSIDE OF ONGOING PHASE III STUDY Source text for Eikon: Further company coverage:",
    "published": "2018-01-09T14:20:00.000+02:00",
    "crawled": "2018-01-09T14:41:11.039+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "clear",
        "pluristem",
        "expanded",
        "access",
        "program",
        "initiate",
        "treatment",
        "critical",
        "limb",
        "ischemia",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "pluristem",
        "therapeutic",
        "inc",
        "pluristem",
        "therapeutic",
        "cleared",
        "co",
        "expanded",
        "access",
        "program",
        "use",
        "cell",
        "treatment",
        "patient",
        "critical",
        "limb",
        "fda",
        "clear",
        "pluristem",
        "expanded",
        "access",
        "program",
        "initiate",
        "treatment",
        "critical",
        "limb",
        "ischemia",
        "outside",
        "ongoing",
        "phase",
        "iii",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}